Lung Disease in Primary Antibody Deficiencies

Area of Science:

• Immunology
• Pulmonology
• Genetics

Background:

• Primary antibody deficiencies (PADs) are common immunodeficiencies linked to severe pulmonary infections and chronic lung disease, notably bronchiectasis.
• Chronic lung disease is a major cause of morbidity and mortality in PAD patients.
• Lung disease in PAD may arise from factors beyond recurrent infections or bronchiectasis.

Purpose of the Study:

• To differentiate interstitial lung disease (ILD) from bronchiectasis in PAD.
• To explore the role of immune dysregulation in PAD-related lung disease.
• To inform diagnostic and therapeutic strategies for lung complications in PAD.

Main Methods:

• Review of monogenic immune dysregulation disorders.
• Analysis of common variable immunodeficiency studies.
• Comparative analysis of bronchiectasis and ILD in PAD patients.

Main Results:

• Interstitial lung disease (ILD) in PAD can result from generalized immune dysregulation, often without prior pneumonia or bronchiectasis.
• ILD development in PAD is associated with specific PAD types, suggesting underlying immunological factors.
• ILD may present earlier and have a greater negative impact on survival than bronchiectasis in PAD.

Conclusions:

• Distinguishing ILD from bronchiectasis is crucial for appropriate management of lung disease in PAD.
• ILD treatment in PAD may require immunomodulatory therapies in addition to standard care for bronchiectasis.
• Further research into PAD lung disease pathogenesis is vital for improved diagnosis, surveillance, and treatment.